You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ilaris

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Treated With Ilaris® for Gouty Arthritis in France

Completed
  • Gouty Arthritis
    • Paris, France
      Novartis
    Jul 20, 2023

    Duchenne Muscular Dystrophy Trial in Washington (Canakinumab Injection [Ilaris])

    Recruiting
    • Duchenne Muscular Dystrophy
    • Canakinumab Injection [Ilaris]
    • Washington, District of Columbia
      Children's National Medical Center
    Mar 1, 2022

    Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Columbus (procedure, biological, other)

    Not yet recruiting
    • Cigarette Smoking-Related Carcinoma
    • Lung Carcinoma
    • Biospecimen Collection
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 6, 2023

    Lung Cancer Trial in Italy (Canakinumab, Placebo)

    Terminated
    • Lung Cancer
    • Rozzano, Milano, Italy, Italy
    • +5 more
    Feb 9, 2023

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • Biospecimen Collection
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 12, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +5 more
    • Canakinumab
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

    Completed
    • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
    • PDR001
    • +4 more
    • Baltimore, Maryland
    • +22 more
    Mar 15, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

    Active, not recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
    • Boston, Massachusetts
    • +1 more
    Apr 5, 2022

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

    Recruiting
    • Rheumatoid Arthritis
    • +2 more
    • Birmingham, Alabama
    • +7 more
    Sep 19, 2022

    Cytokine Release Syndrome in COVID-19-induced Pneumonia Trial (canakinumab)

    No longer available
    • Cytokine Release Syndrome in COVID-19-induced Pneumonia
    • (no location specified)
    Feb 1, 2021

    Coronavirus Infection, Diabetes, Type 2 Trial in Switzerland (Canakinumab, Placebo)

    Completed
    • Coronavirus Infection
    • Diabetes Mellitus, Type 2
    • Aarau, Switzerland
    • +8 more
    Sep 7, 2021

    Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Canakinumab, Quality-of-Life

    Recruiting
    • Lung Carcinoma
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2021

    Canakinumab Administered Subcutaneously in Treatment COVID-19

    Unknown status
    • COVID-19
    • Canakinumab 150 MG/ML [Ilaris]
    • (no location specified)
    Apr 13, 2020

    Schnitzler Syndrome Trial in Leuven (Ilaris)

    Completed
    • Schnitzler Syndrome
    • Ilaris
    • Leuven, Belgium
      UZ Gasthuisberg
    Jul 2, 2019

    Adult-Onset Still´s Disease Trial in Germany (Canakinumab, Placebo)

    Terminated
    Has Results
    • Adult-Onset Still´s Disease
    • Berlin, Germany
    • +13 more
    Jul 17, 2020

    Postprandial Hypoglycemia Trial in Basel, Olten (Canakinumab, Placebo (0.9% NaCl))

    Recruiting
    • Postprandial Hypoglycemia
    • Basel, Switzerland
    • +1 more
    Nov 23, 2022

    Periodic Fever Trial in Petah tikva (Canakinumab)

    Unknown status
    • Periodic Fever
    • Petah tikva, Israel
      SCMCI
    Aug 30, 2018

    Systemic Juvenile Idiopathic Arthritis, Hereditary Periodic Fevers Trial in Bron Cedex, Le Kremlin Bicetre, Paris (canakinumab)

    Completed
    Has Results
    • Systemic Juvenile Idiopathic Arthritis
    • Hereditary Periodic Fevers
    • Bron Cedex, France
    • +2 more
    May 7, 2020

    Schnitzler Syndrome Trial in Germany (Canakinumab, Placebo)

    Completed
    • Schnitzler Syndrome
    • Berlin, Germany
    • +4 more
    Jul 16, 2018

    Alcoholic Hepatitis Trial in United Kingdom (Canakinumab 150mg/ml solution for injection, Placebo)

    Unknown status
    • Alcoholic Hepatitis
    • Canakinumab 150mg/ml solution for injection
    • Placebo
    • Bristol, United Kingdom
    • +15 more
    Feb 8, 2021

    Pyoderma Gangrenosum Trial in Zurich (Canakinumab)

    Completed
    • Pyoderma Gangrenosum
    • Zurich, Switzerland
      Department of Dermatology, University Hospital Zurich
    Sep 26, 2016

    Chronic Idiopathic Urticaria Trial in Zurich (Canakinumab, Placebo)

    Unknown status
    • Chronic Idiopathic Urticaria
    • Zurich, Switzerland
      University Hospital Zurich, Division of Dermatology
    Sep 26, 2016

    A Registry Study of Ilaris (Canakinumab) Patients

    Completed
    • Cryopyrin-associated Periodic Syndromes (CAPS)
    • +3 more
      • Little Rock, Arizona
      • +16 more
      Mar 25, 2016